TCGA Study Provides 'Roadmap' for Targeted Therapy, Genomic Subtyping in Ovarian Cancer

The team performed whole-exome sequencing, mRNA and microRNA expression profiling, methylation analysis, pathway analysis, and genotyping of more than 300 tumor samples, identifying potential treatment strategies and subtypes, and also providing a comprehensive picture of high-grade serous ovarian cancer tumor.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.